📰 Agregator de Știri
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

30.06.2026 15:59 | Euronews Business

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.

🔗 Citește articolul complet pe Euronews Business

🔎 Știri similare din Euronews Business

🆕 Cele mai noi știri

⬅ Înapoi la știri